Filing Details
- Accession Number:
- 0001209191-17-039203
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-12 16:57:30
- Reporting Period:
- 2017-06-08
- Filing Date:
- 2017-06-12
- Accepted Time:
- 2017-06-12 16:57:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1177082 | Daniel Lynch | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-08 | 1,400 | $0.00 | 2,800 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2017-06-08 | 2,500 | $2.09 | 5,300 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-08 | 2,500 | $110.20 | 2,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2017-06-08 | 5,600 | $0.00 | 5,600 | $111.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-06-08 | 2,500 | $0.00 | 2,500 | $2.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,600 | 2027-06-08 | No | 4 | A | Direct | |
| 4,508 | 2021-07-31 | No | 4 | M | Direct |
Footnotes
- These restricted stock units for common stock vest 100% on the earlier of June 8, 2018, or the date of the next annual meeting of stockholders.
- This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on December 14, 2016.
- The range of prices for the transaction reported on this line was $110.00 to $110.65. The average weighted price was $110.1950. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests 100% on the earlier of June 8, 2018, or the date of the next annual meeting of stockholders.
- This option vests over a four-year period in 48 equal monthly installments beginning on April 15, 2011
Billionaire Hedge Funds
